Article
Risk analysis of grade ≥ 2 radiation pneumonitis based on radiotherapy timeline in stage III/IV non-small cell lung cancer: a retrospective study
2022-08-11
Abstract excerpt
<h4>Background: </h4> Radiotherapy is an important treatment for patients with stage III/IV NSCLC, and due to its high incidence of radiation pneumonitis , it is essential to identify high-risk people as early as possible. The present work investigates the value of the application of different phase data throughout the radiotherapy process in analyzing risk of grade ≥2 radiation pneumonitis in stage III/IV NSCLC....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3157efbd-18eb-5104-a738-7d53a6338818
- DOI
- 10.21203/rs.3.rs-1910890/v1
